BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 22535915)

  • 1. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
    Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
    Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
    Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
    J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
    Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
    J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
    Inohara H; Enomoto K; Tomiyama Y; Yoshii T; Osaki Y; Higuchi I; Inoue T; Hatazawa J
    Acta Otolaryngol; 2009 Aug; 129(8):893-9. PubMed ID: 18839385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Doo H; Lee H; Lee JH; Cho KJ; Choi SH; Nam SY; Roh JL
    Oral Oncol; 2011 May; 47(5):376-80. PubMed ID: 21470899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N₀ head and neck cancers.
    Cetin B; Atasever T; Akdemir UO; Senturk S; Tufan G; Turan N; Buyukberber S; Coskun U; Benekli M
    Eur Arch Otorhinolaryngol; 2013 Aug; 270(8):2307-13. PubMed ID: 23283243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Positron Emission Tomography for Node-Positive Head and Neck Cutaneous Squamous Cell Carcinoma.
    Hirshoren N; Olayos E; Herschtal A; Ravi Kumar AS; Gyorki DE
    Otolaryngol Head Neck Surg; 2018 Jan; 158(1):122-126. PubMed ID: 28925330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
    Myers LL; Wax MK
    J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology.
    Stoeckli SJ; Haerle SK; Strobel K; Haile SR; Hany TF; Schuknecht B
    Head Neck; 2012 Apr; 34(4):469-76. PubMed ID: 21604319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.